Kimberly Samson

Employment

• Providence Health & Services

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells
  Nature Communications 2024 DOI: 10.1038/s41467-024-54420-w
  +Save
• Data from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.c.6550335.v1
  +Save
• Data from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.c.6550335
  +Save
• Supplementary Figure 1 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.22543626.v1
  +Save
• Supplementary Figure 1 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.22543626
  +Save
• Supplementary Figure 2 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.22543623.v1
  +Save
• Supplementary Figure 2 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.22543623
  +Save
• Supplementary Table 1 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.22543620.v1
  +Save
• Supplementary Table 1 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.22543620
  +Save
• Supplementary Table 2 from Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
  2023 DOI: 10.1158/2326-6066.22543617.v1
  +Save